Bristol-Myers Squibb Company
Utility Patent Applications
Last updated:
List of all Bristol-Myers Squibb Company patents 438 in total
| Status | Patent |
|---|---|
Application | Utility: 2H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: METHODS OF TREATMENT USING IL-23p19 MONOCLONAL ANTIBODIES Filling date: 6 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: ANTI-ICOS AGONIST ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A BENZOTRIAZOLE MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: ROR GAMMA MODULATORS Filling date: 6 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A TRICYCLIC MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: CARBOHYDRATE CONTENT OF CTLA4 MOLECULES Filling date: 6 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: ANTIBODIES THAT BIND NOVEL PCSK9 VARIANTS Filling date: 6 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: TREATMENT OF C1013G/CXCR4-ASSOCIATED WALDENSTROM'S MACROGLOBULINEMIA WITH AN ANTI-CXCR4 ANTIBODY Filling date: 6 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: TREATMENT OF LUNG CANCER USING AN ANTI-FUCOSYL-GM1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: ANTIBODY-DRUG CONJUGATE WITH A TUBULYSIN ANALOG WARHEAD HAVING A STABILIZED ACETATE GROUP IN THE TUV SUBUNIT Filling date: 6 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: AMINOTRIAZOLOPYRIDINES AS KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: COMBINATION OF TIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: SUBSTITUTED TETRAHYDROCARBAZOLE AND CARBAZOLE CARBOXAMIDE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANTI-CD137 Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: Modified FGF-21 Polypeptides and Uses Thereof Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: NOVEL SUBSTITUTED GLYCINE DERIVED FXIA INHIBITORS Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: DERIVATIVES OF UNCIALAMYCIN, METHODS OF SYNTHESIS AND THEIR USE AS ANTITUMOR AGENTS Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: USE OF ANTI-CTLA-4 ANTIBODIES WITH ENHANCED ADCC TO ENHANCE IMMUNE RESPONSE TO A VACCINE Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: Methods of Selecting Therapeutic Molecules Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: BIARYL KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: MODIFIED SELF-IMMOLATING MOIETIES FOR USE IN PRODRUGS AND CONJUGATES AND METHODS OF USING AND MAKING Filling date: 6 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT Filling date: 6 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: ANTIPROLIFERATIVE COMPOUNDS AND CONJUGATES MADE THEREFROM Filling date: 6 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: TRICYCLIC SULFONE COMPOUND AS A ROR GAMMA MODULATOR Filling date: 6 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: COMPOUNDS USEFUL AS IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION Filling date: 6 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING Filling date: 6 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: METHODS FOR THE SELECTION OF BINDING PROTEINS Filling date: 6 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: TGF BETA RECEPTOR ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: 4-HYDROXY-3-SULFONYLPYRIDIN-2(1H)-ONES AS APJ RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS Filling date: 6 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: HETEROBICYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES Filling date: 6 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: SPIROLACTAMS AS INHIBITORS OF ROCK Filling date: 6 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: (R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ- YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS Filling date: 6 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: SELECTIVE NR2B ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: ANTIBODIES AGAINST MICA AND/OR MICB AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: GSK-3 INHIBITORS Filling date: 6 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: METHODS OF TREATING UROTHELIAL CARCINOMA USING AN ANTI-PD-1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUNDS AS PAR4 INHIBITORS Filling date: 6 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN Filling date: 6 Sep 2025 Issue date: 10 Oct 2019 |
Application | Utility: 3-SULFONYL-5-AMINOPYRIDINE-2,4-DIOL APJ AGONISTS Filling date: 6 Sep 2025 Issue date: 10 Oct 2019 |
Application | Utility: ANTI-TREM-1 ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: CONTROL OF CELL GROWTH THROUGH A TEMPERATURE FEEDBACK LOOP Filling date: 6 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 3 Oct 2019 |
Showing 350 to 400 of 438 patents.